Cargando…
Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
As clinicians and scientists gather more data on the clinical trajectory of COVID-19 and the biology of its causative agent, the SARS-CoV-2 virus, novel strategies are needed to integrate these data to inform new therapies. A recent study by Howell et al. introduces a network model of viral-host int...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033809/ https://www.ncbi.nlm.nih.gov/pubmed/35459899 http://dx.doi.org/10.1038/s41746-022-00599-5 |